FDA Rejects Oleandrin, Extract Pushed By MyPillow CEO, As A Dietary Supplement

The agency concluded that Oleandrin cannot “reasonably be expected to be safe.”

Read the full post on Forbes - Healthcare

Rachel Sandler, Forbes Staff